Copyright(c)2019 Qilu Pharmaceutical Co., Ltd. 鲁ICP备06006222号 Headquarter Address: 8888 Lvyou Road, High-tech Zone, Jinan, 250104, China
Pemetrexed of QILU placed second in the National Award for Science and Technology Progress
National science and technology award meeting was held in Beijing on Jan.16,2013.Five national awards for science and technology were awarded for 330 projects and 7 technology experts, including national top award for science and technology, national award for natural science, national award for technological invention, national award for science and technology progress and national award for international scientific and technical cooperation.
Thereinto, Pemetrexed Disodium developed by QILU Pharma placed second in the National Award for Science and Technology Progress.
Currently, the market share of Pemetrexed Disodium developed by QILU with the trade name SAIZHEN ranks the first in the domestic market because of its better curative effect and less toxic and side effect. Besides, the API is well sold in many countries of the world and the FDF have submitted registration application to USFDA and EDQM.